Home > Products > CD3 & IGF1R
> Recombinant Anti-CD3 x Anti-IGF1R Bispecific Antibody (Fv-IgG)
Recombinant Anti-CD3 x Anti-IGF1R Bispecific Antibody (Fv-IgG) (CAT#: BSDG-092)
Recombinant Anti-CD3 x Anti-IGF1R Bispecific Antibody (Fv-IgG) is an appended IgG format, which has 2+2 antigen-binding valency. This dual variable domain IgG is generated by appending variable domains of an anti-CD3 IgG with similar domains from an anti-IGF1R antibody via short peptide linkers, or vice versa. This BsAb can retarget T cells to tumor cells. It is designed for the research of Melanoma; Colon cancer; Pancreas cancer; Prostate cancer; Kidney cancer therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-IGF1R Bispecific Antibody (Fv-IgG) (BSDG-092). Click the button below to contact us or submit your feedback about this product.